Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration

Published:2020-11-05 Issue:5 Volume:50 Page:275-282
ISSN:1300-0659
Container-title:Turkish Journal of Ophthalmology
language:
Short-container-title:tjo

Author:

Barış Mine Esen^ORCID,Menteş Jale^ORCID,Afrashi Filiz^ORCID,Nalçaçı Serhad^ORCID,Akkın Cezmi^ORCID

Publisher

Galenos Yayinevi

Subject

Ophthalmology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glaucine inhibits hypoxia-induced angiogenesis and attenuates LPS-induced inflammation in human retinal pigment epithelial ARPE-19 cells;European Journal of Pharmacology;2024-10

2. MicroRNA expression profiling in tears and blood as predictive biomarkers for anti-VEGF treatment response in wet age-related macular degeneration;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-04-06

3. Obesity as a Risk Factor for the Ineffectiveness of Antiangiogenic Treatment of Neovascular Age-related Macular Degeneration;Ophthalmology in Russia;2024-03-31

4. Systemic Arterial Hypertension and Ophthalmohypertension as Independent Risk Factors for Poor Response to Antiangiogenic Therapy with Line 1 Drugs in Neovascular Age-related Macular Degeneration;Ophthalmology in Russia;2024-03-31

5. Intravitreal Dexamethasone as a Rescue for Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration with Persistent Disease Activity and High Treatment Demand;Journal of Ocular Pharmacology and Therapeutics;2023-12-20